Tolevamer Potassium Sodium clinical trials
How each study uses Tolevamer Potassium Sodium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- tolevamer potassium-sodium (GT267-004)
- 3
Studies by the year they started
4 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses Tolevamer Potassium Sodium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaCompletedPhase 2Genzyme, a Sanofi CompanyNCT00382304Written as tolevamer potassium-sodium (GT267-004)
- A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaTerminatedPhase 3Genzyme, a Sanofi CompanyNCT00466635Written as GT267-004 (tolevamer potassium sodium)
- A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedPhase 3Genzyme, a Sanofi CompanyNCT00106509Written as tolevamer potassium-sodium (GT267-004)
- A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCompletedPhase 3Genzyme, a Sanofi CompanyNCT00196794Written as Tolevamer potassium-sodium (GT267-004)
Codes
What other systems call Tolevamer Potassium Sodium · ClinicalTrials.gg INT014837
- UNII (FDA) 4A5OM7PI18TOLEVAMER POTASSIUM SODIUMConfirmed FDA, Wikidata
- Wikidata Q96739735Tolevamer Potassium SodiumConfirmed FDA, Wikidata
- NCI Thesaurus C152682Tolevamer Potassium SodiumConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4A5OM7PI18 | TOLEVAMER POTASSIUM SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q96739735 | Tolevamer Potassium Sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152682 | Tolevamer Potassium Sodium | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.